Post-earnings recap
Reported
Thu, Feb 28, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a strong EPS figure, beating expectations significantly. However, the stock declined by 1.13% in reaction, which may indicate investor concerns about the lack of revenue data and future guidance. The cautious tone from management suggests they are aware of challenges ahead.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.13 | N/A | +20.80% |
| Revenue | N/A | N/A | N/A |
Management appeared cautiously optimistic about the company's performance. They noted the positive EPS surprise but did not provide further details on revenue.
Management expressed satisfaction with EPS performance despite lack of revenue data.
They highlighted ongoing efforts to improve operational efficiency.